BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Manchana T, Phowthongkum P, Teerapakpinyo C. Germline mutations in Thai patients with nonmucinous epithelial ovarian cancer. World J Clin Oncol 2019; 10(11): 358-368 [PMID: 31815095 DOI: 10.5306/wjco.v10.i11.358]
URL: https://www.wjgnet.com/2218-4333/full/v10/i11/358.htm
Number Citing Articles
1
Giulia Massari, Francesca Magnoni, Giorgio Favia, Nickolas Peradze, Paolo Veronesi, Carlo La Vecchia, Giovanni Corso. Frequency of CDH1 Germline Mutations in Non-Gastric CancersCancers 2021; 13(10): 2321 doi: 10.3390/cancers13102321
2
Syamel Muhammad, Dheanisa Nofia. Analysis of factors related to the incidence of epithelial ovarian cancer3RD INTERNATIONAL CONFERENCE OF BIO-BASED ECONOMY FOR APPLICATION AND UTILITY 2023; 2730: 070002 doi: 10.1063/5.0127765
3
Tarinee Manchana, Patou Tantbirojn, Natkrita Pohthipornthawat. BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patientsGynecologic Oncology Reports 2020; 33: 100582 doi: 10.1016/j.gore.2020.100582
4
Panupong Sukpan, Surasak Sangkhathat, Hutcha Sriplung, Wison Laochareonsuk, Pongsakorn Choochuen, Nasuha Auseng, Weerawan Khoonjan, Rusta Salaeh, Kornchanok Thangnaphadol, Kasemsun Wanawanakorn, Kanyanatt Kanokwiroon. Exome Sequencing Reveals Novel Germline Variants in Breast Cancer Patients in the Southernmost Region of ThailandJournal of Personalized Medicine 2023; 13(11): 1587 doi: 10.3390/jpm13111587
5
Vera M. Witjes, Majke H.D. van Bommel, Marjolijn J.L. Ligtenberg, Janet R. Vos, Marian J.E. Mourits, Margreet G.E.M. Ausems, Joanne A. de Hullu, Tjalling Bosse, Nicoline Hoogerbrugge. Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysisGynecologic Oncology 2022; 164(1): 221 doi: 10.1016/j.ygyno.2021.10.072
6
Songporn Oranratnachai, Watchalawalee Yamkaew, Atchara Tunteeratum, Thongchai Sukarayothin, Nareenart Iemwimangsa, Ravat Panvichien. Characteristics of breast cancer patients tested for germline BRCA1/2 mutations by next‐generation sequencing in Ramathibodi Hospital, Mahidol UniversityCancer Reports 2023; 6(1) doi: 10.1002/cnr2.1664